Skip to content
  • Architects of Change
  • Video library
  • Pledges
  • News
#100daysmission
Find out more
  • Architects of Change
  • Video library
  • Pledges
  • News

News

CEPI, UK Government, and Life Sciences Industry unite around 100 Days Mission

Industry has stepped forward to commit its expertise and resources to work towards developing vaccines in 100 days.

08 Mar 2022

Japan pledges $300 million to CEPI

This investment comes as the world strives to end COVID-19 and better prepare for future threats.

25 Feb 2022

UK pledges £160 million to CEPI

The announcement comes ahead of the UK Government hosting the Global Pandemic Preparedness Summit.

24 Feb 2022

New global vaccine trial launched to evaluate fractional COVID-19 booster shots

CEPI will provide up to US $8.7 million (AU $12.3million) to support the trial, led by the Murdoch Children’s Research Institute (MCRI), Australia, with support from PATH.

21 Feb 2022

CEPI, THSTI and Panacea Biotec partner to develop broadly protective Betacoronavirus vaccines

CEPI will provide funding of up to $12.5m to support the development of multi-epitope, nanoparticle-based vaccine candidates and advance the manufacturing process. 

21 Feb 2022

CEPI expands collaboration to develop COVID-19 multi-variant vaccine

OSLO, Norway, SHANGHAI and KUNMING, China; 8 February 2022: CEPI, the Coalition for Epidemic Preparedness Innovations, today announced that it will expand its collaboration with Shanghai Zerun Biotechnology Co., Ltd. (Zerun Bio) and its parent company Walvax Biotechnology Co., Ltd. (Walvax), a public company listed on the Shenzhen Stock Exchange (300142.SZ) to advance the development of...

08 Feb 2022

CEPI opens Call to develop heat-stable vaccine tech

The aim is to use these new tools to improve global access to vaccines through reducing complex-cold chain requirements and potential vaccine wastage.

08 Feb 2022
1 2 3 4 5 6
  • CEPI Home
  • EndPandemics
  • Twitter
  • LinkedIn
  • Privacy and Cookie Policy
© 2022 CEPI.